Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RDHL

Updated 10/6/2026, 8:26 AM ET.

RDHL

RedHill Biopharma Ltd.

Sale$1,431

Raday Gilead

Chief Operating Officer

14,310,000 shat $0.00Filed Oct 6, 7:00 AM ETFiling
RDHL

RedHill Biopharma Ltd.

Sale$1,413

Raday Gilead

Chief Operating Officer

14,130,000 shat $0.00Filed Jul 13, 4:03 PM ETFiling

Read from public SEC filings. Not financial advice.